Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays the completed phase 2 study of interleukin-2 and pembrolizumab for metastatic kidney cancer, including its treatment plan, eligibility criteria, outcome measures, investigators, and study documents.
    Difference
    50%
    Check dated 2026-11-11T01:53:18.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden message instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-04T00:18:53.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH transition notice appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:26:12.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The site revision indicator changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:40:47.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, indicating an access/permission issue that prevents viewing the record.
    Difference
    19%
    Check dated 2026-09-23T00:24:47.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays the updated platform revision (v3.7.0) in place of the previous v3.6.6, indicating a site-wide update without altering the study details.
    Difference
    0.1%
    Check dated 2026-09-15T23:53:07.000Z thumbnail image

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.